GENEVA, June 19 -- PURE STORAGE, INC. filed a patent application (US2025/055747) for “SECURITY POLICY ANALYSIS AND UPDATING USING GENERATIVE ARTIFICIAL INTELLIGENCE (AI)”. With publication no. WO/2026... Read More
GENEVA, June 19 -- BRISTOL-MYERS SQUIBB COMPANY filed a patent application (US2025/055738) for “5-(PYRIDIN-4-YL)-3H-IMIDAZO[4,5-B]PYRIDINE DERIVATIVES AS CAMK2 INHIBITORS FOR THE TREATMENT OF HEART FA... Read More
GENEVA, June 19 -- SEYOND, INC. filed a patent application (US2025/055739) for “METALENS FOR LIDAR LIGHT RECEIVER”. With publication no. WO/2026/107426, here are the other details related to the paten... Read More
GENEVA, June 19 -- CLARK ATLANTA UNIVERSITY, INC. filed a patent application (US2025/055740) for “ANTIBACTERIAL COMPOUNDS AND METHODS OF ISOLATING FROM THUJA ARBORVITAE”. With publication no. WO/2026/... Read More
GENEVA, June 19 -- BRISTOL-MYERS SQUIBB COMPANY filed a patent application (US2025/055732) for “6-(PYRIDIN-4-YL)-1H-BENZO[D]IMIDAZOLE DERIVATIVES AS CAMK2 INHIBITORS FOR THE TREATMENT OF HEART FAILURE... Read More
GENEVA, June 19 -- METSERA, INC. filed a patent application (US2025/055735) for “ORAL PEPTIDES AND USES THEREOF FOR WEIGHT LOSS, WEIGHT MAINTENANCE, AND MANAGEMENT OF METABOLIC CONDITIONS”. With publi... Read More
GENEVA, June 19 -- BRISTOL-MYERS SQUIBB COMPANY filed a patent application (US2025/055736) for “N-(4-(IMIDAZO[4,5-B]PYRIDIN-5-YL)-2-PYRIDYL)BENZAMIDE DERIVATIVES AS CAMK2 INHIBITORS FOR THE TREATMENT ... Read More
GENEVA, June 19 -- BRISTOL-MYERS SQUIBB COMPANY filed a patent application (US2025/055725) for “N-(4-(1H-BENZO[D[IMIDAZOL-6-YL)-PYRIDIN-2-YL)BENZAMIDE DERIVATIVES AS CAMK2 INHIBITORS FOR THE TREATMENT... Read More
GENEVA, June 19 -- FLAGSHIP PIONEERING INNOVATIONS VII, LLC filed a patent application (US2025/055726) for “REGULATORY ELEMENTS AND RELATED METHODS”. With publication no. WO/2026/107419, here are the ... Read More
GENEVA, June 19 -- BRISTOL-MYERS SQUIBB COMPANY filed a patent application (US2025/055730) for “1 H-BENZO[D]IMIDAZOLE DERIVATIVES AS CAMK2 INHIBITORS FOR THE TREATMENT OF HEART FAILURE”. With publicat... Read More